Renuvion Safely and Effectively Treats Lax Skin in Trial
In a Phase II study, the Renuvion device improved the appearance of lax skin in 82.5% of subjects after 6 months.
In a Phase II study, the Renuvion device improved the appearance of lax skin in 82.5% of subjects after 6 months.
The platform integrates fat removal, closed-loop contouring, tissue contraction, and electrosurgical capabilities.
Emily Hu, MD, shares insights from a recent report on HA injectables, examining patient perceptions, persistent myths, and clinical realities.